The diagnostic and prognostic value of galectin‐3 in patients at risk for heart failure with preserved ejection fraction: results from the DIAST‐CHF study

AIMS: Galectin‐3 (Gal‐3) predicts long‐term outcome among patients with heart failure (HF) with preserved ejection fraction (HFpEF). The ability of Gal‐3 to diagnose and predict incident HFpEF in a cohort at risk for HFpEF is of particular interest. We aimed to determine the association between Gal‐...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ESC Heart Fail
Main Authors: Trippel, Tobias Daniel, Mende, Meinhard, Düngen, Hans‐Dirk, Hashemi, Djawid, Petutschnigg, Johannes, Nolte, Kathleen, Herrmann‐Lingen, Christoph, Binder, Lutz, Hasenfuss, Gerd, Pieske, Burkert, Wachter, Rolf, Edelmann, Frank
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8006663/
https://ncbi.nlm.nih.gov/pubmed/33566456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.13174
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados